Quarterly report pursuant to Section 13 or 15(d)

Equity (Details)

v3.23.3
Equity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
1 Months Ended 9 Months Ended
Aug. 31, 2020
Sep. 30, 2023
Sep. 30, 2022
Equity (Details) [Line Items]      
Gross proceeds   $ 13,419 $ 18,264
Vesting period   4 years  
Expected life   6 years  
Expected dividends   zero  
Capital on Demand Sales Agreement [Member]      
Equity (Details) [Line Items]      
Aggregate value of common stock $ 200,000    
Sale of common stock, shares (in Shares)   1,700 3,000
Gross proceeds   $ 13,800 $ 18,900
Net proceeds   $ 13,400 18,300
Restricted Stock Units [Member]      
Equity (Details) [Line Items]      
Expected life   1 year 10 months 24 days  
Unrecognized compensation expense   $ 1,100  
Recorded compensation expense   400 100
Fair value   $ 1,800  
Minimum [Member]      
Equity (Details) [Line Items]      
Exercise price (in Dollars per share)   $ 6.33  
Discount rate percentage   3.50%  
Expected volatility percentage   80.60%  
Maximum [Member]      
Equity (Details) [Line Items]      
Exercise price (in Dollars per share)   $ 11.6  
Discount rate percentage   4.32%  
Expected volatility percentage   81.60%  
Stock Options [Member]      
Equity (Details) [Line Items]      
Employees purchase shares of common stock (in Shares)   166  
Vesting period   10 years  
Options of aggregated fair value   $ 1,000  
Expected life   2 years 8 months 12 days  
Unrecognized compensation expense   $ 7,700  
Recorded compensation expense   $ 2,400 $ 1,600